Skip to content
OpenCapital
Get started

ClearPoint Neuro CLPT Q4 2025 Annual earnings

Reported March 17, 2026 · After market close

Revenue$10.4MBeat by $350.0KDiluted EPS-$0.27Miss by $0.05
Revenue estimate$10.1M
EPS estimate-$0.22

Next report

Aug 11, 2026 (in a month)
Revenue estimate$12.7M
EPS estimate-$0.27

Financials

Q4 2025

Income statement

See full
Revenue$10.4M+34.0%
Gross profit$6.4M+34.5%
Operating income-$7.0M-25.0%
Net income-$7.8M-44.6%
EPS (diluted)-$0.27-35.0%

Balance sheet

See full
Cash & equivalents$47.0M+134%
Total debt$58.2M+1,532%
Total equity$28.0M+10.4%
Total assets$97.7M+149%

Cash flow

See full
Operating cash flow-$12.1M-870%
CapEx$49.0K-81.4%
Free cash flow-$12.1M-704%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$406.96M-4.1%
Enterprise value$418.22M+2.6%
P/S11×-2.5×

Profitability

See full
Gross margin61.4%+0.5pp
Operating margin-65.4%+2.7pp
Net margin-69.1%+11.9pp
FCF margin-66.1%-333pp

Returns & leverage

See full
Return on equity-95.6%+20.6pp
Debt / equity2.1×+1.9×
Current ratio5.9×+2.7×

Segments

By product

See full
Biologics And Drug Delivery$5.2M+22.7%
Neurosurgery Navigation And Therapy$4.7M+61.4%
Neurosurgery Navigation And Therapy Disposable Products$4.7M—
Biologics And Drug Delivery Services And License Fees$2.8M-3.8%
Biologics And Drug Delivery Disposable Products$2.4M+81.4%

Versus estimates

Revenue

Q1 2026$12.1MBeat by $161.3K
Q4 2025$10.4MBeat by $350.0K
Q3 2025$8.9MMiss by $1.5MQ2 2025$9.2MMiss by $585.0KQ1 2025$8.5MMiss by $681.7KQ4 2024$7.8MMiss by $458.7K

Diluted EPS

Q1 2026-$0.32Miss by $0.04
Q4 2025-$0.27Miss by $0.05
Q3 2025-$0.21Miss by $0.01Q2 2025-$0.21Miss by $0.01Q1 2025-$0.22Miss by $0.07Q4 2024-$0.20Miss by $0.05

Ask the moment ClearPoint Neuro reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ClearPoint Neuro report Q4 2025 earnings?
ClearPoint Neuro (CLPT) reported Q4 2025 earnings on March 17, 2026 after market close.
What were ClearPoint Neuro's Q4 2025 revenue and EPS?
ClearPoint Neuro reported revenue of $10.4M and diluted EPS of $-0.27 for Q4 2025.
Did ClearPoint Neuro beat estimates in Q4 2025?
Revenue beat the consensus estimate of $10.1M by $350.0K. EPS missed the consensus estimate of $-0.22 by $0.05.
How did ClearPoint Neuro's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 33.8% from $7.8M a year earlier and diluted EPS declined 35.0% from $-0.20.
Where can I find ClearPoint Neuro's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-110780) and the 10-K periodic report (0001193125-26-111231) directly on SEC EDGAR. The filing index links above go to sec.gov.